BMY depends on Reblozyl, Opdualag and Breyanzi to offset revenue hits from generics and Medicare Part D impacts.

Safe dividend-paying income stocks trading under $30 are passive income home runs. Stocks trading under the $30 level offer Boomers a larger share count when they buy. With the geopolitical ...

Pfizer’s shares (currently trading at $24.29) have posted a disappointing 8.5% loss while the S&P 500 was flat. This may have ...

PFE faces a decline in COVID revenues, LOE pressure and IRA impacts but rising EPS estimates offer a glimmer of resilience.

Discover 23 high-dividend stocks that outshine treasuries! Learn why growing dividends signal financial strength and explore ...

There is perhaps no better way to put a $500,000 windfall to work than to stash it in a self-directed investment portfolio.

Despite Amazon being banned from visiting the premises of the European Parliament, representatives from the US e-commerce ...

The PfE group’s members have for months demanded full transparency in connection with the contracts of NGOs funded by the ...

The company’s strategy focuses on steadily increasing its dividend, reinvesting in the business with strong financial returns, and carrying out value-driven share buybacks.

Buried in the heaps of data collected by the Securities and Exchange Commission (SEC) are the inauspiciously-named 13F ...

In addition to Bernstein, Pfizer also received a Hold from Wells Fargo’s Mohit Bansal in a report issued on June 17. However, on the same day, Guggenheim maintained a Buy rating on Pfizer (NYSE: PFE).

Pfizer is undervalued as markets fixate on its patent cliff, overlooking strong cash flows, pipeline upside, and a 7% yield.